SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for eHealth, Inc. (EHTH) (CIK 0001333493) (EHTH) — Aug 25, 2010

eHealth, Inc. (EHTH) (CIK 0001333493)
Date: Aug. 25, 2010 · CIK: 0001333493 · Accession: 0000000000-10-049154

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-33071

Date
August 25, 2010
Author
Jeffrey P. Riedler
Form
UPLOAD
Company
eHealth, Inc. (EHTH) (CIK 0001333493)

Letter

August 25, 2010

Gary L. Lauer Chairman of the Board of Directors, President and Chief Executive Officer eHealth, Inc. 440 East Middlefield Road Mountain View, CA 94043 Re: eHealth, Inc. Form 10-K Filed March 5, 2010 File No. 001-33071 Dear Mr. Lauer: We have limited our review of your filing to those issues we have addressed in our comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter within te n business days by providing the requested information or by advising us when you will provide the requested response. If you do not believe our comments apply to your facts and circum stances, please tell us w hy in your response. After reviewing the information you provide in response to these comments, we may have additional comments. Form 10-K, filed March 5, 2010

Carrier Relationships, page 4 1. We note that eHealth, Inc. en ters into contractual agency relationships with health insurance carriers that are non- exclusive and terminable on sh ort notice by either party for any reason. Revenue derived from three of these carriers, Aetna, Wellpoint and UnitedHealthcare, represented 16%, 15% and 14 % of total revenue in 2009, respectively. Please provide disclosure to be included in your Form 10-K regardi ng the material terms of these contracts with Aetna, Wellpoint and UnitedHealthcare including fee and payment, term and termination and any other material provisions and file as exhibits the contracts underlying these three contractual ag ency relationships. Alternatively tell us the basis for your belief that you are not require d to file the agreements pursuant to Item 601(b)(10)(ii)(B) of Regulation S-K.

Gary L. Lauer eHealth, Inc. August 25, 2010 Page 2

Schedule 14A

Executive Compensation, page 23

2. Please confirm that your 2011 proxy statement will discuss the factors the compensation committee considered in exercising its discre tion with respect to individual performance when awarding cash bonuses. Additionally, c onfirm that you will discuss the level of achievement of the company performance goals.

Compensation Risk Analysis

3. We note that you have not included any disc losure in response to Item 402(s) of Regulation S-K. Please advise us of the basis for your conclusion that disclosure is not necessary and describe the process yo u undertook to reach that conclusion.

Diversity

4. We note that you have not included any disclosu re in response to Item 407(c)(2)(vi) of Registration S-K. Please discuss whether the nominating committee considers diversity in identifying nominees for di rector. If the committee has a policy with regard to the consideration of diversity in identifying director nominees describe how the policy is implemented and how the committee assesses th e effectiveness of the policy. See Item 407(c)(2)(vi) of Regulation S-K. We urge all persons who are responsible for th e accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable Exchange Act rules requir e. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made. In responding to our comments, please provi de a written statement from the company acknowledging that: • the company is responsible for the adequacy and accuracy of the disclo sure in the filing;

• staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

• the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federa l securities laws of the United States.

Gary L. Lauer eHealth, Inc. August 25, 2010 Page 3

Please contact Johnny Gharib at (202) 551- 3170 or Suzanne Hayes at (202) 551-3675 with any questions. Sincerely,

Jeffrey P. Riedler Assistant Director

Show Raw Text
August 25, 2010

Gary L. Lauer Chairman of the Board of Directors,  President and Chief Executive Officer eHealth, Inc.
440 East Middlefield Road
Mountain View, CA 94043
Re: eHealth, Inc.  Form 10-K
Filed March 5, 2010 File No.  001-33071
 Dear Mr. Lauer:
 We have limited our review of your filing to  those issues we have addressed in our
comments.  In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.
 Please respond to this letter within te n business days by providing the requested
information or by advising us when you will provide the requested response.  If you do not believe our comments apply to your facts and circum stances, please tell us w hy in your response.
 After reviewing the information you provide in response to these comments, we may
have additional comments.
Form 10-K, filed March 5, 2010

Carrier Relationships, page 4
1. We note that eHealth, Inc. en ters into contractual agency  relationships with health
insurance carriers that are non- exclusive and terminable on sh ort notice by either party
for any reason.  Revenue derived from three of these carriers, Aetna, Wellpoint and
UnitedHealthcare, represented 16%, 15% and 14 % of total revenue in  2009, respectively.
Please provide disclosure to be included in  your Form 10-K regardi ng the material terms
of these contracts with Aetna, Wellpoint and UnitedHealthcare including fee and
payment, term and termination and any other material provisions and file as exhibits the contracts underlying these three contractual ag ency relationships. Alternatively tell us the
basis for your belief that you are not require d to file the agreements pursuant to Item
601(b)(10)(ii)(B) of Regulation S-K.

Gary L. Lauer eHealth, Inc.
August 25, 2010 Page 2

Schedule 14A

Executive Compensation, page 23

2. Please confirm that your 2011 proxy statement will discuss the factors the compensation
committee considered in exercising its discre tion with respect to individual performance
when awarding cash bonuses.  Additionally, c onfirm that you will discuss the level of
achievement of the company performance goals.

Compensation Risk Analysis

3. We note that you have not included any disc losure in response to Item 402(s) of
Regulation S-K.  Please advise us of the basis for your conclusion that disclosure is not
necessary and describe the process yo u undertook to reach that conclusion.

Diversity

4. We note that you have not included any disclosu re in response to Item 407(c)(2)(vi) of
Registration S-K.  Please discuss whether the nominating committee considers diversity
in identifying nominees for di rector.  If the committee has a policy with regard to the
consideration of diversity in  identifying director nominees  describe how the policy is
implemented and how the committee assesses th e effectiveness of the policy.  See Item
407(c)(2)(vi) of Regulation S-K.  We urge all persons who are responsible for th e accuracy and adequacy of the disclosure
in the filing to be certain that the filing include s the information the Securities Exchange Act of
1934 and all applicable Exchange Act rules requir e.  Since the company and its management are
in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.
 In responding to our comments, please provi de a written statement from the company
acknowledging that:
• the company is responsible for the adequacy and accuracy of the disclo sure in the filing;

• staff comments or changes to disclosure in response to staff comments do not foreclose
the Commission from taking any action with respect to the filing; and

• the company may not assert staff comments as a defense in any proceeding initiated by
the Commission or any person under the federa l securities laws of  the United States.

Gary L. Lauer eHealth, Inc. August 25, 2010 Page 3

Please contact Johnny Gharib at (202) 551- 3170 or Suzanne Hayes at (202) 551-3675
with any questions.
Sincerely,

Jeffrey P. Riedler Assistant Director